Clinical Trial Update: Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers

View source ↗

Summary

This clinical trial update discusses using FDG-PET imaging and molecular markers to evaluate breast cancer response to neoadjuvant anthracycline-based chemother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Breast Neoplasms, Breast Cancer | Status: UNKNOWN